Ballast Inc
AZN icon

Ballast Inc’s AstraZeneca AZN Stock Holding History

Ballast Inc’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$230K Hold
1,424
– – 0.04% 153
2026
Q2 		$270K Buy
+1,424
New +$268K 0.05% 137

Other funds holding AZN

Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
ASR Vermogensbeheer
ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return
Generali Asset Management
Generali Asset Management Trieste, Italy $5.73B AUM 29.6% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
ZWJ Investment Counsel
ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return

Ballast Inc's AZN Position: Q3 2026 in Review

Ballast Inc held its AstraZeneca (AZN) position steady in Q3 2026 at 1,424 shares worth $230K. The position accounts for 0.04% of the portfolio, ranked #153.

Ballast Inc first reported a position in AZN in Q2 2026 and has held it in 2 quarters since. The position peaked at $270K in Q2 2026. 463 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Ballast Inc held 1,424 shares of AstraZeneca worth $230K as of Q3 2026.
  • Ballast Inc left its AstraZeneca share count unchanged in Q3 2026.
  • AstraZeneca made up 0.04% of Ballast Inc's portfolio in Q3 2026, its #153 holding.
  • Ballast Inc first reported a position in AstraZeneca in Q2 2026 and has held it in 2 quarters since.
  • Ballast Inc's AstraZeneca position peaked at $270K in Q2 2026.
  • 463 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Ballast Inc's 13F filing for Q3 2026, filed 20 Oct 2026.